## Note
nid: 1495629799342
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies::Pembrolizumab, #AK_Step1_v11::#FirstAid::04_Pathology::03_Neoplasia::05_Immune_Checkpoint_Interactions, #AK_Step1_v11::#FirstAid::04_Pathology::03_Neoplasia::05_Immune_Checkpoint_Interactions::Pembrolizumab, #AK_Step1_v11::#OME_banner, #AK_Step1_v11::#SketchyPharm::08_Antineoplastics::Cancer_Immunotherapy, #AK_Step1_v11::^Other::^EXPN, #AK_Step1_v11::^Other::^HighYield::4-LowerYield
markdown: false

### Text
<div>
  <div>
    Because <b>Pembrolizumab</b> targets a peripheral tolerance
    mechanism, patients taking this drug can develop autoimmune
    disorders of {{c1::endocrine}} organs
  </div>
</div>

### Extra
<div>
  Ex thyroid, pancreas, pituitary gland, and the kidney
  <div>
    <i>Inflammation of each endocrine organ can cause dysfunctions
    one would expect (kidney - nephritic syndrome, pancreas - T1DM
    ...)</i>
  </div>
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy
#REF!

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_7.png"></a>
</div>

### Additional Resources


### One by one

